BioSpace News Archive

Biotechnology company Inventprise announced that a Phase 1/2 clinical study of its 25-valent pneumococcal conjugate vaccine has begun in Halifax, Canada.

Aravive, Inc., a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, reported financial results for the third quarter ended September 30, 2022 and provided corporate updates.

Sobi North America announced that the U.S. FDA issued an emergency use authorization for KINERET® for the treatment of COVID-19 in adult patients who are hospitalized with positive results of direct SARS-CoV-2 viral testing with pneumonia, requiring supplemental oxygen, and are at risk of progressing to severe respiratory failure, and are likely to have an increased blood level of a certain suPAR that may be a sign of increased risk of worsening of the disease.

Purple Biotech Ltd. announced that Gil Efron, Chief Executive Officer of Purple Biotech, and Fabien Sebille, Chief Business Officer, will present a corporate overview of the Company’s clinical development programs at the Jefferies London Healthcare Conference on Wednesday, November 16, 2022 at 7:25 am GMT.

Pluri Inc., a leading biotechnology company, won Cell Innovation award in the Cell Biology category of the second annual BioTech Breakthrough Awards.

Bio-Techne Corporation announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Stephens Annual Investment Conference on Thursday, November 17, 2022, at 10:00 a.m. CST.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences.